Literature DB >> 30448536

Pseudoacromegaly.

Pedro Marques1, Márta Korbonits2.   

Abstract

Individuals with acromegaloid physical appearance or tall stature may be referred to endocrinologists to exclude growth hormone (GH) excess. While some of these subjects could be healthy individuals with normal variants of growth or physical traits, others will have acromegaly or pituitary gigantism, which are, in general, straightforward diagnoses upon assessment of the GH/IGF-1 axis. However, some patients with physical features resembling acromegaly - usually affecting the face and extremities -, or gigantism - accelerated growth/tall stature - will have no abnormalities in the GH axis. This scenario is termed pseudoacromegaly, and its correct diagnosis can be challenging due to the rarity and variability of these conditions, as well as due to significant overlap in their characteristics. In this review we aim to provide a comprehensive overview of pseudoacromegaly conditions, highlighting their similarities and differences with acromegaly and pituitary gigantism, to aid physicians with the diagnosis of patients with pseudoacromegaly.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acromegaloidism; Acromegaly; Gigantism; Overgrowth; Pseudoacromegaly; Tall stature

Mesh:

Year:  2018        PMID: 30448536     DOI: 10.1016/j.yfrne.2018.11.001

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  4 in total

1.  Pachydermoperiostosis mimicking the acral abnormalities of acromegaly.

Authors:  Pedro Marques; Maria Stelmachowska-Banas; David Collier; Florian Wernig; Márta Korbonits
Journal:  Endocrine       Date:  2020-01-08       Impact factor: 3.633

2.  Pseudoacromegaly Associated with Non-Functioning Pituitary Adenoma.

Authors:  Awatef Alotaibi; Ahmad Habib; Moutaz Osman; Khaled Alzahrani; Faisal Alzahrani
Journal:  Eur J Case Rep Intern Med       Date:  2020-10-09

Review 3.  The clinical aspects of pituitary tumour genetics.

Authors:  Judit Dénes; Márta Korbonits
Journal:  Endocrine       Date:  2021-02-04       Impact factor: 3.633

4.  GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.

Authors:  Vinaya Srirangam Nadhamuni; Donato Iacovazzo; Jane Evanson; Anju Sahdev; Jacqueline Trouillas; Lorraine McAndrew; Tom R Kurzawinski; David Bryant; Khalid Hussain; Satya Bhattacharya; Márta Korbonits
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.